Circulating levels of insulin-like growth factor (IGF) binding protein- 1 and -3 in aging men: Relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1484-1491

  Benbassat, Carlos A ^a   Maki, Kevin C ^b,c   Unterman, Terry G ^a,d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Vet Admin H   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PRASTERONE SULFATE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; AGING; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031006203     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.5.1484     Document Type: Article

References (46)

1. Rudman D. 1985 Growth hormone, body composition, and aging. J Am Geriatr Soc. 33:300-307.
2. Corpas E, Harman SM, Blackman, MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.
3. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
4. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-32.
5. Shimasaki S, Ling N. 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGEBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res. 3:243-266.
6. Lee PDK, Conover CA, Powell DR. 1993 Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med. 204:4-29.
7. Baxter RC. 1991 Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability Acta Paediatr Scand. 372(Suppl):107-114.
8. Oh Y, Muller HL, Lamson G, Rosenfeld RG. 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem. 268:14964-14971.
9. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. 1995 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367.
10. Zapf J, Hauri C, Waldvogel M, et al. 1989 Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci USA. 86:3813-3817.
11. Dai J, Baxter RC. 1994 Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex. Endocrinology. 135:2335-2341.
12. Hilding A, Brismar K, Degerblad M, Thoren M, Hall K. 1995 Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficiency patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab. 80:2646-2652.
13. Phillips LS, Unterman TG. 1984 Somatomedin activity in disorders of nutrition and metabolism. Clin Endocrinol Metab. 13:145-189.
14. Nguyen-Yamamoto L, Deal CL, Finkelstein JA, Van Vliet G. 1994 Hormonal control of growth in the genetically obese Zucker rat. I. Linear growth, plasma Insulin-like growth factor-1 (IGF-I) and IGF-binding proteins. Endocrinology. 134:1382-1388.
15. Unterman TG, Oehler DT, Murphy LJ, Lacson RG. 1991 Multihormonal regulation of insulin-like growth factor-binding protein-1 in rat H4IIE hepatoma cells: the dominant role of insulin. Endocrinology. 128:2693-2701.
16. Powell DR, Suwanichkul A, Cubbage ML, DePaolis LA, Snuggs MB, Lee PDK. 1991 Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem. 266:18868-18876.
17. Orlowski CC, Ooi GT, Brown DR, Yang YW-H, Tseng LY-H, Rechler MM. 1991 Insulin rapidly inhibits insulin-like growth factor binding protein-1 gene expression in H4-II-E rat hepatoma cells. Mol Endocrinol. 5:1180-1187.
18. Defronzo RA. 1979 Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes. 28:1095-1101.
19. Rutanen E-M, Karkkaninen T, Stenman U-H, Yki-Jarvinen H. 1993 Aging is associate with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J Clin Endocrinol Metab. 77:1152-1155.
20. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC. 1991 Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology. 129:2254-2256.
21. Cotterill AM, Cowell CT, Silink M. 1989 Insulin and variation in glucose levels modify the secretion rates of the growth hormone-independent insulin-like growth factor binding protein-1 in the human hepatoblastoma cell line Hep G2. J Endocrinol. 123:R17-R20.
22. Orentreich N, Brind JL, Rizer RL, Vogelman JH. 1984 Age changes and sex differences in serum Dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:551-555.
23. Nestler JE, Barlascini CO, Clore JN, Blackard WG. 1988 Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 66:57-61.
24. Frystyk J, Skjaerbaek C, Dinesen B, Orskov H. 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348:185-191.
25. Chang YT, Kulin HE, Garibaldi L, Suriano MJ, Bracki K, Pang S. 1993 Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3β-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab. 77:1251-1257.
26. Lohman TG, Roche AF, Martorell R, eds. 1991 Anthropometric standardization reference manual. Champaign: Human Kinetics Press.
27. Heymsfield SB, McManus C, Smith J, Nixon DW. 1982 Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Nutr. 36:680-690.
28. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DR, Turner RC. 1985 Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412-419.
29. Haffner SM, Gonzalez C, Miettinen H, Kennedy E, Stern MP. 1996 A prospective analysis of the HOMA model. Diabetes Care. 19:1138-1141.
30. Fink RI, Kolterman OG, Grifin J, Olefsky JM. 1996 Mechanisms of insulin resistance in aging. J Clin Invest. 71:1523-1535.
31. Fraze E, Chiou M, Chen I, Reaven GM. 1987 Age-related changes in postprandial plasma glucose, insulin and free fatty acid concentrations in nondiabetic individuals. J Am Geriatr Soc. 35:224-228.
32. Rasmussen MH, Hvidberg A, Juul A, et al. 1995 Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab. 80:1407-1415.
33. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Acta Endocrinol (Copenh). 41:85-93.
34. Baum HBA, Biller BMK, Katznelson L, et al. 1996 Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men-a clinical research center study. J Clin Endocrinol Metab. 81:84-92.
35. Toogood AA, O'Neil PA, Shalet SM. 1996 Beyond the somatopause: growth deficiency in adults over the age of 60 years. J Clin Endocrinol Metab. 81:460-465.
36. Seneviratne C, Luo J, Murphy LJ. 1990 Transcriptional regulation of rat insulin-like growth factor-binding protein-1 expression by growth hormone. Mol Endocrinol. 4:1199-1204.
37. Kachra Z, Itamar B, Yannopoulos C, Khan MH, Guyda HJ, Posner BI. 1991 The differential regulation by glucagon and growth hormone of insulin-like growth factor (IGF)-I and IGF binding proteins in cultured rat hepatocytes. Endocrinology. 128:1723-1730.
38. Laron Z, Suikkari AM, Klinger B, et al. 1992 Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature. Acta Endocrinol (Copenh). 127:351-358.
39. Berdanier CD, Parente JA, McIntosh MK. 1993 Is Dehydroepiandrosterone an antiobesity agent? FASEB J. 7:414-419.
40. Montanini V, Simoni M, Chiossi G, et al. 1988 Age-related changes in plasma Dehydroepiandrosterone sulphate, cortisol, testosterone and free testosterone circadian rhythms in adult men. Horm Res. 29:1-6.
41. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. 1994 Effects of replacement dose of Dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 78:1360-1367.
42. Garn SM, Leonard WR, Hawthorne VM. 1986 Three limitations of the body mass index. Am J Clin Nutr. 44:996-997.
43. Lewitt MS, Baxter RC. 1990 Inhibitors of glucose uptake stimulate the production of insulin-like factor-binding protein (IGFBP-1) by human fetal liver. Endocrinology. 126:1527-1533.
44. Rajkumar KD, Barron MS, Lewitt MS, Murphy LJ. 1995 Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology. 136:4029-4091.
45. Snyder DK, Clemmons DR. 1990 Insulin-dependent regulation of insulin-like growth factor-binding protein-1. J Clin Endocrinol Metab. 71:1632-1936.
46. Best JD, Kahn SE, Ader M, Watanabe RM, Ni T-C, Bergman RN. 1996 Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care. 19:1018-1030.